undamentalytics Newsletter
Sign in

Ensign Group, Inc (ENSG) stock

Add to watchlist

Add holding +

NASDAQ: ENSG Nasdaq Health Care Facilities Next results ~February 3, 2027

C+ Fundamentals grade

Ensign Group, Inc is a US-listed company in the health care facilities industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$270

Cash-flow model

Base case. Range ~$210–$350 across our lower- and higher-growth cases (12.2%–22.2% a year).

Price vs value

Undervalued

The price is below our entire value range; our base value is 51% above it.

Price used: $179.06, November 2, 2026

Ensign Group, Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 10 selling0 purchases and 49 sales by directors and officers, last 12 monthsInsider trades
  • Funds241 adding, 309 cuttingOf 74 active managers that changed their stake, 48 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Ensign Group files

10-Q filed October 27: Ensign

Model value −22.4%

Revenue for the twelve months to September 2026 reached $5.67bn, up 17.5% on a year earlier. That pace cooled from 18.9% a quarter earlier, yet it still ranks 1 of 9 among the health care facilities companies we cover. Free cash flow margin improved to 10.1% from 7.9% a year earlier, lifting the fundamentals grade from C to C+. Our model value drops from $329 to $255 a share, set against a share price of $175. The rating stays Buy. At $175, the market is pricing in roughly 9.6% a year of cash flow growth over five years. That falls well short of the 16.6% a year revenue growth already delivered.

Source: 10-Q filed October 27, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where Ensign stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $5.49bn, up 18.9% on a year earlier, about the same pace as a quarter earlier. Free-cash-flow margin rose to 11.1% from 10.0% a year earlier. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 6 of our 7 financial-health checks. Our cash-flow model value is $342 a share, against a share price of $174. At that price, our model says the market is pricing in about 6.1% a year of cash-flow growth for five years, slower than the 15.9% a year revenue growth it has delivered.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 3, 2027 (estimated)

Ensign Group, Inc's trailing-twelve-month revenue grew 17.5% year on year, with a free-cash-flow margin of 10.1%. Where it stands out: free-cash-flow margin of 10.1% ranks 2 of 13 health care facilities companies we cover.

Our discounted-cash-flow model values the business at ~$270 per share in the base case (~$210–$350 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 50.4% while net income grew 21.6%: a 29pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $179.06 is 51% below our value per share of $270.
  • Fast growth. Revenue grew 17.5% over the last 12 months, against a median of 14.0% for health care facilities companies we cover.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Insiders selling. 10 insiders sold $14M of stock over the past 365 days and none bought (100% under pre-set trading plans).

Latest results: FY2026 Q3

Filed October 27, 2026
Earnings per share
$2.03 against an average estimate of $1.97: beat by 3.1%
Revenue
$1.48bn, up 14.5% on a year earlier
Share reaction
+4.1% in the first session after the results on October 27, 2026, against +0.9% for the S&P 500
Guidance given
annual earnings guidance $7.94 to $8.02 (annual 2026); annual revenue guidance $5.89bn to $5.92bn (annual 2026)
Next report
October 27, 2026; average EPS estimate $2.11

Ensign Group's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.4%
  • 1 week+1.2%
  • 1 month+4.2%
  • This year+2.9%
  • 1 year-0.4%
  • 5 years+130.9%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$5.7B
Operating margin
9.0%
Net margin
7.0%
EPS (TTM, diluted)
$6.71

Growth

Revenue growth
+17.5%
Change in growth rate
−1.4 pts
Share count change
+1.3%

Cash

Free cash flow (TTM)
$575M
FCF margin
10.1%
Stock pay % of revenue
1.1%

Earnings

Last results
October 27, 2026
Next results (est.)
February 3, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Guidance
  3. Our research
  4. Announcement
  5. Announcement
  6. Announcement
  7. Announcement
  8. Dividend
  9. Governance
  10. Financing
  11. Agreement
  12. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Ensign Group, Inc valuation models and calculator

What the price is pricing in

The share price implies about 8.8% a year of cash-flow growth for five years.That is slower than the 16.6% a year revenue growth Ensign Group has delivered.

  • Priced in8.8%
  • Last 12 months17.5%
  • 3 years a year16.8%
  • 5 years a year16.6%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($180.03, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Buy12-month view
12-month price target
~$270
Price used
$180.03close November 3, 2026
Implied change
▲ +51%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Ensign Group, Inc's free cash flow after stock-based pay with after-tax interest added back ($422M, FY2026 Q3 TTM), growing 14.4% and 15.7% in the next two years (forecasts, guidance and its record), then back to 17.2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$210–~$350 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Ensign Group, Inc's free cash flow after stock-based pay ( $422M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Ensign Group, Inc as an operating company, with every model that fits that kind of business. Cost of equity 8.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.69 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$270 ~$210–$350 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$100 ~$81–$140 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$140 ~$97–$220 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$130 ~$100–$160 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$180 ~$100–$270 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Ensign Group, Inc with Health Care Facilities in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −24%
  • Revenue growth 5 points higher ▲ +31%
  • Free-cash-flow margin 1 point lower ▼ −10%
  • Last year's free-cash-flow margin change, if it persists ▲ +27%
  • Discount rate 1 point higher ▼ −16%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $108$145$194$260$345$454
8.5% $83$110$146$192$253$331
10% $68$89$117$152$199$258

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$20.08$20.24$35.55$44.62$72.04$83.15$93.95$111.69$132.50$174.01$179.06
Market value$1.0bn$1.1bn$1.9bn$2.5bn$4.0bn$4.7bn$5.3bn$6.4bn$7.7bn$10.2bn$10.6bn
+ Net debt (− = net cash)$226m$274m−$31m$271m−$119m−$102m−$160m−$357m−$316m−$360m−$139m
Enterprise value$1.3bn$1.3bn$1.9bn$2.8bn$3.9bn$4.6bn$5.2bn$6.0bn$7.4bn$9.9bn$10.5bn
Multiples
Price / sales 0.6x0.7x1.1x1.2x1.7x1.8x1.8x1.7x1.8x2.0x1.9x
Price / earnings 20.9x26.4x20.9x22.6x23.6x24.3x23.8x30.6x25.9x29.8x26.7x
Price / free cash flow 127.8x42.0x12.1x20.7x10.8x17.2x19.6x17.0x22.2x18.2x15.3x
EV / EBITDA 9.8x15.7x14.7x15.4x14.0x14.6x14.4x18.4x16.7x18.7x16.7x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

55 /100

Moderate moat

How hard Ensign Group's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 8 / 20

    Net income has been a median 6.2% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 21.2%, moving by 1.3 percentage points (standard deviation) across 9 years.

  • Durability 9 / 20

    Operating margin has been a median 8.6%; its worst year was 4.7%.

  • Cash conversion 14 / 20

    Free cash flow was positive in 9 of 9 years, at a median 7.9% of revenue.

  • Discipline 15 / 20

    The diluted share count rose 4.6% over five years; stock-based pay has been a median 0.7% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $7.88 +20% $5.9bn +17%
Next $8.67 +10% $6.6bn +12%

Next year's EPS estimate has moved +1.3% in 90 days, across 5 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +1.1% on 90 days ago. In the last 30 days, 5 analysts raised Ensign Group, Inc's forecast and 0 cut it.

Consensus EPS forecast Ensign Group, Inc, last 90 days
$7.50 $8.00 $8.50 $9.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $7.79 Current fiscal year, 60 days ago: $7.79 Current fiscal year, 30 days ago: $7.79 Current fiscal year, 7 days ago: $7.81 Current fiscal year, Now: $7.88 $7.88 Next fiscal year, 90 days ago: $8.55 Next fiscal year, 60 days ago: $8.55 Next fiscal year, 30 days ago: $8.55 Next fiscal year, 7 days ago: $8.59 Next fiscal year, Now: $8.67 $8.67

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $7.79$8.55
60 days ago $7.79$8.55
30 days ago $7.79$8.55
7 days ago $7.81$8.59
Now $7.88$8.67

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $1.97 $2.03 +3.1%
Jun 2026 $1.85 $1.92 +4.0%
Mar 2026 $1.82 $1.85 +1.8%
Dec 2025 $1.77 $1.82 +3.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 27, 2026
  • annual revenue guidance annual 2026 $5.89bn to $5.92bn Raised
    “We are also raising the lower end of our annual revenue guidance to $5.89 billion, while maintaining the upper end at $5.92 billion.” source
  • annual earnings guidance annual 2026 $7.94 to $8.02 Raised
    “Due to the strength of the third quarter and our confidence in the fourth quarter, we are increasing our annual 2026 earnings guidance to $7.94 to $8.02 per diluted share, up from our original guidance of $7.75 to $7.85.” source
  • tax rate assumption annual 2026 about 25% Maintained vs about 25
    “Management's annual guidance is based on diluted weighted average common shares outstanding of approximately 59.5 million and a 25.0% tax rate.” source
  • diluted weighted average common shares outstanding annual 2026 about 59.5m
    “Management's annual guidance is based on diluted weighted average common shares outstanding of approximately 59.5 million and a 25.0% tax rate.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Ensign Group, Inc's revenue by +14.4% next year and +15.7% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+13.5%, weight 42%) , management guidance (+13.6%, weight 35%) and the company's own record (+17.2%, weight 23%) . How the weights are set.

Analyst recommendations

4 analysts, Oct 2026
Buy375%
Hold125%
Sell00%

Monthly trend

  1. Oct 20261214
  2. Sep 20261315
  3. Aug 20261315

Counts of recommendations published by analysts covering Ensign Group, Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
3.0%
of tradable shares
Days to cover
4.19
at average volume
Short interest, 1 month
+0%
to September 30, 2026
Held by institutions
92%
of shares
Held by insiders
3.5%
of shares
Employees
46,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −0.4%

$179.83 on October 31, 2025 to $179.06

ThenNowEffect
Revenue (last 12 months) $4.6bn $5.5bn +18.9%
Net margin 7.0% 6.9% −1.3%
P/E multiple 32.6x 28.1x −13.9%
Share count 59m 59m −1.4%

Biggest factor: revenue.

Last 3 years +76.5%

$101.48 on November 3, 2023 to $179.06

ThenNowEffect
Revenue (last 12 months) $3.4bn $5.5bn +62.0%
Net margin 7.1% 6.9% −2.8%
P/E multiple 24.1x 28.1x +16.6%
Share count 57m 59m −3.9%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
ENSG+15%+13%+19%+19%+31%+3%
Industry peers (median)+21%−9%+9%+12%+30%+13%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
ENSG50%58%67%58%67%27%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
ENSG−28%−25%−14%−15%−19%−32%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 56% from July 31, 2019 to March 16, 2020. Getting back needed a 125% gain, reached on August 7, 2020, 144 days after the low.

Price behaviour

52-week range
$147.02 – $215.59
From 52-week high
−16.9%
vs 50-day average
+2.5%
vs 200-day average
−1.3%
Volatility (1 year)
30%
Beta vs S&P 500
-0.06

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
9 up, 3 down
typical move ±4.8%
After a week
8 up, 3 down
typical move ±6.3%
After a month
7 up, 4 down
typical move ±9.9%
Results releasedNext dayS&P 500 next day5 days21 days
October 27, 2026 +4.1% +0.9% — —
July 27, 2026 +5.9% +0.3% +2.5% +3.5%
April 30, 2026 −1.4% +1.3% −6.5% −11.5%
February 4, 2026 +13.6% −1.7% +22.1% +19.4%
November 3, 2025 +2.2% −1.0% +0.8% −0.6%
July 24, 2025 +7.8% +0.5% +7.7% +23.8%
April 29, 2025 +1.5% +0.7% +5.1% +15.3%
February 5, 2025 −6.5% +0.8% −13.2% −10.3%
October 24, 2024 +1.9% +0.2% +3.3% −2.4%
July 25, 2024 +4.5% +0.6% +2.2% +8.4%
May 1, 2024 −1.5% +0.6% −1.9% +2.4%
February 1, 2024 +6.7% +2.4% +4.3% +11.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Ensign Group, Inc’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade C+ (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Ensign Group, Inc in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Ensign Group, Inc
$3.5B $4B $4.5B $5B $5.5B $6B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $3.7B Revenue (TTM), FY24 Q1: $3.9B Revenue (TTM), FY24 Q2: $4B Revenue (TTM), FY24 Q3: $4.1B Revenue (TTM), FY24 Q4: $4.3B Revenue (TTM), FY25 Q1: $4.4B Revenue (TTM), FY25 Q2: $4.6B Revenue (TTM), FY25 Q3: $4.8B Revenue (TTM), FY25 Q4: $5.1B Revenue (TTM), FY26 Q1: $5.3B Revenue (TTM), FY26 Q2: $5.5B Revenue (TTM), FY26 Q3: $5.7B $5.7B

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $3.7B
FY24 Q1 $3.9B
FY24 Q2 $4B
FY24 Q3 $4.1B
FY24 Q4 $4.3B
FY25 Q1 $4.4B
FY25 Q2 $4.6B
FY25 Q3 $4.8B
FY25 Q4 $5.1B
FY26 Q1 $5.3B
FY26 Q2 $5.5B
FY26 Q3 $5.7B
Revenue growth, TTM YoY Ensign Group, Inc
10% 15% 20% 25% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 23.3% Revenue growth, TTM YoY, FY24 Q1: 20.4% Revenue growth, TTM YoY, FY24 Q2: 17.1% Revenue growth, TTM YoY, FY24 Q3: 15.5% Revenue growth, TTM YoY, FY24 Q4: 14.2% Revenue growth, TTM YoY, FY25 Q1: 14.8% Revenue growth, TTM YoY, FY25 Q2: 16.3% Revenue growth, TTM YoY, FY25 Q3: 17.5% Revenue growth, TTM YoY, FY25 Q4: 18.7% Revenue growth, TTM YoY, FY26 Q1: 19.2% Revenue growth, TTM YoY, FY26 Q2: 18.9% Revenue growth, TTM YoY, FY26 Q3: 17.5% 17.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 23.3%
FY24 Q1 20.4%
FY24 Q2 17.1%
FY24 Q3 15.5%
FY24 Q4 14.2%
FY25 Q1 14.8%
FY25 Q2 16.3%
FY25 Q3 17.5%
FY25 Q4 18.7%
FY26 Q1 19.2%
FY26 Q2 18.9%
FY26 Q3 17.5%
Operating margin (TTM) Ensign Group, Inc
6% 7% 8% 9% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 6.8% Operating margin (TTM), FY24 Q1: 6.8% Operating margin (TTM), FY24 Q2: 6.8% Operating margin (TTM), FY24 Q3: 6.8% Operating margin (TTM), FY24 Q4: 8.4% Operating margin (TTM), FY25 Q1: 8.5% Operating margin (TTM), FY25 Q2: 8.6% Operating margin (TTM), FY25 Q3: 8.3% Operating margin (TTM), FY25 Q4: 8.4% Operating margin (TTM), FY26 Q1: 8.5% Operating margin (TTM), FY26 Q2: 8.5% Operating margin (TTM), FY26 Q3: 9.0% 9.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 6.8%
FY24 Q1 6.8%
FY24 Q2 6.8%
FY24 Q3 6.8%
FY24 Q4 8.4%
FY25 Q1 8.5%
FY25 Q2 8.6%
FY25 Q3 8.3%
FY25 Q4 8.4%
FY26 Q1 8.5%
FY26 Q2 8.5%
FY26 Q3 9.0%
FCF margin (TTM) Ensign Group, Inc
6% 8% 10% 12% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 8.2% FCF margin (TTM), FY24 Q1: 7.5% FCF margin (TTM), FY24 Q2: 6.1% FCF margin (TTM), FY24 Q3: 6.1% FCF margin (TTM), FY24 Q4: 6.2% FCF margin (TTM), FY25 Q1: 6.7% FCF margin (TTM), FY25 Q2: 8.0% FCF margin (TTM), FY25 Q3: 7.9% FCF margin (TTM), FY25 Q4: 9.1% FCF margin (TTM), FY26 Q1: 9.2% FCF margin (TTM), FY26 Q2: 9.0% FCF margin (TTM), FY26 Q3: 10.1% 10.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 8.2%
FY24 Q1 7.5%
FY24 Q2 6.1%
FY24 Q3 6.1%
FY24 Q4 6.2%
FY25 Q1 6.7%
FY25 Q2 8.0%
FY25 Q3 7.9%
FY25 Q4 9.1%
FY26 Q1 9.2%
FY26 Q2 9.0%
FY26 Q3 10.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Ensign Group took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $5.1B
  2. Other income $30M · 0.6%
  3. Cost of revenue $4B · 79.5%
  4. Gross profit $1B · 20.5%
  5. Selling, general and admin $270M · 5.3%
  6. Other operating costs $344M · 6.8%
  7. Operating income $425M · 8.4%
  8. Income tax $111M · 2.2%
  9. Net income $344M · 6.8%

Shares of revenue. Source: Ensign Group's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained. Other income is income outside operations, such as investment gains.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 1,655 1,598 1,755 2,037 2,403 2,627 3,025 3,729 4,260 5,058 5,674
Gross profit 313 285 336 416 537 608 671 788 884 1,039 1,203
EBITDA 131 85 130 180 278 316 359 328 442 530 630
Operating income 92 43 85 129 223 260 297 255 358 425 509
Net income 50 40 92 111 170 195 225 209 298 344 399
Diluted EPS $0.96 $0.77 $1.70 $1.97 $3.06 $3.42 $3.95 $3.65 $5.12 $5.84 $6.71
Growth (year on year)
Revenue — −3.4% +9.8% +16.1% +18.0% +9.4% +15.1% +23.3% +14.2% +18.7% +17.5%
EBITDA — −34.5% +51.9% +38.9% +54.1% +13.9% +13.5% −8.7% +35.0% +19.7% +25.6%
Operating income — −53.0% +96.6% +52.1% +72.7% +16.7% +14.0% −14.0% +40.3% +18.7% +26.6%
Net income — −19.0% +128.2% +19.7% +54.2% +14.2% +15.4% −6.8% +42.3% +15.4% +21.6%
Diluted EPS — −19.8% +120.8% +15.9% +55.3% +11.8% +15.5% −7.6% +40.3% +14.1% +20.0%
Margins
Gross margin 18.9% 17.8% 19.2% 20.4% 22.4% 23.1% 22.2% 21.1% 20.7% 20.5% 21.2%
EBITDA margin 7.9% 5.3% 7.4% 8.9% 11.6% 12.0% 11.9% 8.8% 10.4% 10.5% 11.1%
Operating margin 5.6% 2.7% 4.8% 6.3% 9.3% 9.9% 9.8% 6.8% 8.4% 8.4% 9.0%
Net margin 3.0% 2.5% 5.3% 5.4% 7.1% 7.4% 7.4% 5.6% 7.0% 6.8% 7.0%
Free-cash-flow margin 0.5% 1.6% 9.1% 5.9% 15.5% 10.5% 9.0% 10.1% 8.1% 11.2% 12.3%
Cash flow
Cash from operations 74 80 210 192 373 276 273 377 347 564 696
Capital spending 66 54 51 72 0 0 0 0 0 0 0
Free cash flow 8 25 159 121 373 276 273 377 347 564 696
Stock-based pay 9 8 8 11 15 19 23 31 36 48 62
Free cash flow after stock pay −1 18 151 109 359 257 250 346 311 516 634
Balance sheet
Cash 58 42 31 59 237 262 316 510 465 504 338
Total debt 284 316 — 330 118 160 156 152 148 144 199
Net debt (negative = net cash) 226 274 −31 271 −119 −102 −160 −357 −316 −360 −139
Diluted shares 52m 53m 54m 56m 56m 57m 57m 57m 58m 59m 59m
Returned to shareholders
Dividends 8 9 9 10 11 12 12 13 14 14 15
Buybacks 30 7 0 6 25 10 30 0 0 20 47
Total returned 38 16 9 17 36 22 42 13 14 34 62

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

6 of 7 checks passed · September 30, 2026
What it owns · $6.0bn
Short-term assets $1.2bnLonger-term assets $4.8bn
What it owes, and who funded it · $6.0bn
Short-term liabilities $963mLonger-term liabilities $2.5bnShareholders' equity $2.6bn
  • Short-term assets cover short-term liabilities $1.2bn of assets due within a year against $963m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.2bn short-term assets against $2.5bn of longer-dated liabilities.
  • More cash than debt $338m of cash against $199m of debt.
  • Debt below 40% of shareholders' equity Debt is 8% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 14% to 8% over five years.
  • A year's operating cash flow covers at least 20% of debt $696m of operating cash flow against $199m of debt.
  • Operating profit covers interest at least five times over Operating income of $509m against $8m of interest.

From Ensign Group, Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$47.4M
Dividends (TTM)
$15M
Returned to shareholders
11%
of free cash flow
Buybacks, last 3 fiscal years
$20M
Diluted share count
+1.3%
year over year
Total shareholder yield
0.6%
dividends 0.1% + buybacks 0.5% of market value
Dividend payout ratio
4%
of net income paid out
Days sales outstanding
43 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care facilities
Last 12 months unless stated ENSG PACS ACHC SGRY BKD CON Median
Revenue, last 12 months $5.7bn $5.6bn $3.4bn $3.4bn $3.1bn $2.3bn $3.1bn
Revenue growth, last 12 months 17.5% 15.2% 4.3% 4.0% −4.4% 14.0% 14.0%
Revenue growth, 3-year average 16.8% — 6.6% 8.1% 1.0% — 8.1%
Revenue growth, latest quarter 14.5% 9.1% −0.4% 2.7% −11.6% 10.0% 8.6%
Gross margin 21.2% — — 23.1% 26.9% — 21.2%
Operating margin 9.0% 7.4% 28.7% 11.4% 3.5% 16.4% 9.0%
Operating margin, 3-year average 8.0% 5.2% 23.7% 11.5% 1.8% 15.9% 7.9%
Net margin 7.0% 4.8% −33.4% −2.6% −4.5% 8.7% 4.8%
Cash from operations / revenue 12.3% 10.3% 6.3% 7.7% 7.3% 14.7% 7.7%
Free-cash-flow margin 10.1% 8.2% −4.0% 5.6% 0.8% 11.7% 4.7%
Free-cash-flow margin, 3-year average 8.1% 5.9% −9.5% 6.0% −0.5% 10.2% 5.9%
Stock pay / revenue 1.1% 1.3% 0.9% 0.3% 0.4% 0.6% 0.6%
Change in share count 1.3% −4.5% −1.1% 1.3% 3.7% 1.6% 0.9%

Median of all 13 companies we cover in health care facilities. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

13 health care facilities companies
Measure Company Peer median Rank
Revenue growth Growth 17.5% 14.0% 5 of 13
Change in growth rate Growth -1.4pp -1.4pp 7 of 13
Operating margin Profitability 9.0% 9.0% 5 of 9
Net margin Profitability 7.0% 4.8% 6 of 13
Free-cash-flow margin Cash generation 10.1% 4.7% 2 of 13
Stock pay as % of revenue Cash generation 1.1% 0.6% 9 of 12
Long-term debt as % of assets Balance sheet 3.2% 37.7% 2 of 13
Change in share count Balance sheet 1.3% 0.9% 9 of 13
Days sales outstanding Balance sheet 43 days 48 days 6 of 12

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue YoY
Skilled Services $4.8B ▲ 18.7%
Standard Bearer $0 —

These categories overlap or exclude eliminations, so shares aren't shown.

From Ensign Group, Inc's 10-K filed February 4, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$8.4B
Institutions reporting
542
Shares held vs prior quarter
▼ 1.5%
Positions opened / closed
72 / 97

Top buyers and sellers, Q2 2026: 241 institutions bought and 309 sold ; the biggest buyer was Capital Research Global Investors (+618K shares) and the biggest seller Blackrock, Inc (−1.5M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $937M 5.8M 11.1% ▼ 20.6%
Baillie Gifford & Co $806M 5.0M 9.6% ▲ 4.2%
Vanguard Portfolio Management LLC $460M 2.9M 5.5% ▼ 8.1%
Vanguard Capital Management LLC $421M 2.6M 5.0% ▲ 1.2%
FMR LLC $407M 2.5M 4.8% ▲ 10.6%
Wasatch Advisors LP $365M 2.3M 4.3% ▲ 10.7%
Capital Research Global Investors $324M 2.0M 3.8% ▲ 44.0%
State Street Corp $288M 1.8M 3.4% ▼ 12.9%
Geode Capital Management, LLC $267M 1.7M 3.2% ▼ 1.1%
Arrowstreet Capital, Limited Partnership $172M 1.1M 2.0% ▲ 134.9%
Dimensional Fund Advisors LP $154M 964K 1.8% ▲ 0.3%
Norges Bank $117M 729K 1.4% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Ensign Group, Inc's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $13.6M 49 trades by 10 insiders · 100% under pre-set plans
Net ▼ $13.6M net selling
Insider Date Trade Shares Price Value
Parkinson Mark Vincent Director October 16, 2026 Sell pre-set plan 100 $179.62 $17,962
Blouin Ann Scott Director July 27, 2026 Sell pre-set plan 200 $185.00 $37,000
Blouin Ann Scott Director July 27, 2026 Sell pre-set plan 175 $181.88 $31,829
Agwunobi John O Director July 20, 2026 Sell pre-set plan 392 $171.06 $67,056
Parkinson Mark Vincent Director July 16, 2026 Sell pre-set plan 100 $168.12 $16,812
Smith Barry M Director June 2, 2026 Sell pre-set plan 700 $164.28 $114,996
Smith Barry M Director May 4, 2026 Sell pre-set plan 700 $182.21 $127,547
Agwunobi John O Director April 20, 2026 Sell pre-set plan 392 $199.97 $78,388
Parkinson Mark Vincent Director April 16, 2026 Sell pre-set plan 100 $196.60 $19,660
Smith Barry M Director April 2, 2026 Sell pre-set plan 700 $196.65 $137,655
Smith Barry M Director March 2, 2026 Sell pre-set plan 700 $213.02 $149,114
Uychiat Pison Marivic Director February 20, 2026 Sell pre-set plan 67 $204.92 $13,730

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around February 3, 2027 estimated from the company's past filing pattern, not announced

  • October 27, 2026
  • July 27, 2026
  • April 30, 2026
  • February 4, 2026
  • November 3, 2025
  • July 24, 2025

Recent SEC filings

Data status

When each part of this page on Ensign Group, Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Ensign Group, Inc in brief

What does Ensign Group, Inc do?
Ensign Group, Inc is a US-listed company in the health care facilities industry. Its financial year ends in December.
What is Ensign Group, Inc's stock ticker?
Ensign Group, Inc trades under the ticker ENSG on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Ensign Group, Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Ensign Group, Inc reported revenue of $5.7B, 17.5% higher than a year earlier, according to its SEC filings.
What is Ensign Group, Inc's free cash flow?
Ensign Group, Inc's free-cash-flow margin is 10.1% of revenue over the trailing twelve months, ranking 2 of the 13 health care facilities companies we cover.
What is Ensign Group, Inc's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Ensign Group, Inc's free cash flow after stock-based pay gives ~$270 per share in the base case, and ~$210–$350 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Ensign Group, Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Baillie Gifford & Co and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Ensign Group, Inc buying back stock, and does it pay a dividend?
Ensign Group, Inc spent $47.4M on share repurchases over the trailing twelve months, and its diluted share count still rose 1.3% over the year.
What is Ensign Group, Inc's market cap?
On November 2, 2026, Ensign Group, Inc's market capitalisation was about $10.6B, with a price-to-earnings ratio of 26.7 and net debt of -$139M. Market figures come from third-party market data and may be delayed.
Does Ensign Group, Inc pay a dividend?
Yes: Ensign Group, Inc paid $15M in dividends over the trailing twelve months, a dividend yield of 0.14% and a payout ratio of 3.8%.
How much debt does Ensign Group, Inc have?
Ensign Group, Inc's debt-to-equity ratio is 7.8%, from its latest balance sheet (14.3% five years earlier). The financial health section below sets out its other solvency checks.
Who are Ensign Group, Inc's competitors?
In our Health Care Facilities peer group, the companies closest to Ensign Group, Inc are Pacs Group, Inc., Acadia Healthcare Company, Inc., Surgery Partners, Inc., Brookdale Senior Living Inc. and Concentra Group Holdings Parent, Inc. The side-by-side comparison below sets their revenue, margins and growth against Ensign Group, Inc's.
Are insiders buying or selling Ensign Group, Inc stock?
Over the last 12 months, Ensign Group, Inc's directors and officers reported 0 open-market purchases and 49 sales on Form 4. The insider trading page charts every trade.
When is Ensign Group, Inc's next earnings date?
Around February 3, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Ensign Group, Inc announces its own schedule.